How do updates in regards to emergency IND patients go? Does CYDY have to get permission from the patients and the FDA to discuss details? Maybe just a general, “they improved,” is all they can say.

Again, it’s going to be hard to prove leronlimab is what caused their improvement (assumed) until more patients are injected and until the phase 2 trial starts.